Rosemary A. Crane, Director at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 2,860 shares at $11.90 ($34K) on 2020-08-11, disclosed to the SEC on 2020-08-13.
Open-market sale of $34k TEVA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.